These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25732823)

  • 1. DBC1 functions as a tumor suppressor by regulating p53 stability.
    Qin B; Minter-Dykhouse K; Yu J; Zhang J; Liu T; Zhang H; Lee S; Kim J; Wang L; Lou Z
    Cell Rep; 2015 Mar; 10(8):1324-34. PubMed ID: 25732823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis.
    Magni M; Ruscica V; Buscemi G; Kim JE; Nachimuthu BT; Fontanella E; Delia D; Zannini L
    Nucleic Acids Res; 2014 Dec; 42(21):13150-60. PubMed ID: 25361978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions.
    Qiang L; Kon N; Zhao W; Jiang L; Knight CM; Welch C; Pajvani U; Gu W; Accili D
    Cell Rep; 2015 Jun; 11(11):1797-808. PubMed ID: 26074075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination.
    Akande OE; Damle PK; Pop M; Sherman NE; Szomju BB; Litovchick LV; Grossman SR
    Cell Rep; 2019 Mar; 26(12):3323-3335.e4. PubMed ID: 30893604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of the deacetylase SIRT1 by DBC1.
    Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W
    Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation.
    Seo SK; Hwang CS; Choe TB; Hong SI; Yi JY; Hwang SG; Lee HG; Oh ST; Lee YH; Park IC
    Oncotarget; 2015 Sep; 6(28):26528-40. PubMed ID: 25605253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.
    Zheng H; Yang L; Peng L; Izumi V; Koomen J; Seto E; Chen J
    Mol Cell Biol; 2013 Dec; 33(24):4960-70. PubMed ID: 24126058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells.
    Jin L; Li C; Xu Y; Wang L; Liu J; Wang D; Hong C; Jiang Z; Ma Y; Chen Q; Yu F
    Oncol Rep; 2013 May; 29(5):1983-90. PubMed ID: 23483203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
    Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
    Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
    Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
    Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damage.
    Park JH; Lee SW; Yang SW; Yoo HM; Park JM; Seong MW; Ka SH; Oh KH; Jeon YJ; Chung CH
    Nat Commun; 2014 Nov; 5():5483. PubMed ID: 25406032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library.
    Huang C; Wu S; Ji H; Yan X; Xie Y; Murai S; Zhao H; Miyagishi M; Kasim V
    Sci Adv; 2017 Oct; 3(10):e1701383. PubMed ID: 29057323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.